<VariationArchive VariationID="2034759" VariationName="NM_152490.5(B3GALNT2):c.1209_1257dup (p.Lys420fs)" VariationType="Duplication" Accession="VCV002034759" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2090107" VariationID="2034759">
      <GeneList>
        <Gene Symbol="B3GALNT2" FullName="beta-1,3-N-acetylgalactosaminyltransferase 2" GeneID="148789" HGNC_ID="HGNC:28596" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q42.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="235439796" stop="235504452" display_start="235439796" display_stop="235504452" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NW_014040927.1" start="83388" stop="148044" display_start="83388" display_stop="148044" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="235610532" stop="235667780" display_start="235610532" display_stop="235667780" Strand="-" />
          </Location>
          <OMIM>610194</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_152490.5(B3GALNT2):c.1209_1257dup (p.Lys420fs)</Name>
      <CanonicalSPDI>NC_000001.11:235454209:GGAGATCACATATCCTGACCCACATGCAAAGGCAGGGTAAGCGGGGCTCGG:GGAGATCACATATCCTGACCCACATGCAAAGGCAGGGTAAGCGGGGCTCGGAGATCACATATCCTGACCCACATGCAAAGGCAGGGTAAGCGGGGCTCGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1q42.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="235454209" stop="235454210" display_start="235454209" display_stop="235454210" variantLength="49" positionVCF="235454209" referenceAlleleVCF="T" alternateAlleleVCF="TGGAGATCACATATCCTGACCCACATGCAAAGGCAGGGTAAGCGGGGCTC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="235617521" stop="235617522" display_start="235617521" display_stop="235617522" variantLength="49" positionVCF="235617521" referenceAlleleVCF="T" alternateAlleleVCF="TGGAGATCACATATCCTGACCCACATGCAAAGGCAGGGTAAGCGGGGCTC" />
      </Location>
      <ProteinChange>K420fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.235617524_235617572dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.235617524_235617572dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.235454212_235454260dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.235454212_235454260dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009230.2" sequenceAccession="NG_009230" sequenceVersion="2" change="g.91787_91835dup">
            <Expression>NG_009230.2:g.91787_91835dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033219.2" sequenceAccession="NG_033219" sequenceVersion="2" change="g.55224_55272dup">
            <Expression>NG_033219.2:g.55224_55272dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033219.3" sequenceAccession="NG_033219" sequenceVersion="3" change="g.55194_55242dup">
            <Expression>NG_033219.3:g.55194_55242dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_152490.5" sequenceAccession="NM_152490" sequenceVersion="5" change="c.1209_1257dup" MANESelect="true">
            <Expression>NM_152490.5:c.1209_1257dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_689703.1" sequenceAccession="NP_689703" sequenceVersion="1" change="p.Lys420fs">
            <Expression>NP_689703.1:p.Lys420fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_152490.5(B3GALNT2):c.1209_1257dup (p.Lys420fs) AND Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11" Accession="RCV002877151" Version="2">
        <ClassifiedConditionList TraitSetID="9507">
          <ClassifiedCondition DB="MedGen" ID="C3554638">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-10-08" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">26663670</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33290285</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9507" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17747" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A11</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, B3GALNT2-RELATED</ElementValue>
                <XRef Type="MIM" ID="615181" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11</ElementValue>
                <XRef ID="MONDO:0014071" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MDDGA11</ElementValue>
                <XRef Type="MIM" ID="615181" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15915" />
                <XRef ID="15915" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="588" DB="Orphanet" />
              <XRef ID="899" DB="Orphanet" />
              <XRef ID="C3554638" DB="MedGen" />
              <XRef ID="MONDO:0014071" DB="MONDO" />
              <XRef Type="MIM" ID="615181" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5929091" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="17699513|MedGen:C3554638" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003238231" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26663670</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33290285</ID>
          </Citation>
          <Comment>This variant has not been reported in the literature in individuals affected with B3GALNT2-related conditions. This sequence change creates a premature translational stop signal (p.Lys420Glufs*36) in the B3GALNT2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 81 amino acid(s) of the B3GALNT2 protein. This variant is not present in population databases (gnomAD no frequency). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant disrupts a region of the B3GALNT2 protein in which other variant(s) (p.Pro474del) have been determined to be pathogenic (PMID: 26663670, 33290285). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="B3GALNT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.235617521_235617522insGGAGATCACATATCCTGACCCACATGCAAAGGCAGGGTAAGCGGGGCTC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3554638" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5929091" TraitType="Disease" MappingType="XRef" MappingValue="C3554638" MappingRef="MedGen">
        <MedGen CUI="C3554638" Name="Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

